← All Investors
BENITEC BIOPHARMA INC
BNTC
Holders
2
Combined Value
$8M
Combined Shares
823,786
Current Price
$11.80
52W High
$16.76
vs 52W High
−29.6%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Israel Englander - Millennium Management | $6M | 0.00% | ~$13.30 | −11.3% | Bought Q1 2026 | Q1 2026 |
| Ken Griffin - Citadel Advisors | $1M | 0.00% | ~$10.94 | +7.9% | Bought Q1 2026 | Q1 2026 |
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Ken Griffin - Citadel Advisors | BUY | +$1M | ~$10.65 |
| Q1 2026 | Israel Englander - Millennium Management | BUY | +$414K | ~$10.65 |
| Q4 2025 | Israel Englander - Millennium Management | NEW BUY | +$8M | ~$13.47 |
| Q4 2025 | Ken Griffin - Citadel Advisors | NEW BUY | +$236K | ~$13.47 |
| Q2 2025 | Israel Englander - Millennium Management | SOLD OUT | −$416K | ~$13.01 |
| Q1 2025 | Israel Englander - Millennium Management | NEW BUY | +$416K | ~$13.01 |
| Q4 2024 | Ken Griffin - Citadel Advisors | SOLD OUT | −$130K | ~$9.19 |
| Q3 2024 | Ken Griffin - Citadel Advisors | NEW BUY | +$130K | ~$9.19 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 2 | 823,786 | +30.6% | $8M | $10.65 |
| Q4 2025 | 2 | 630,740 | +1868.2% | $8M | $13.47 |
| Q1 2025 | 1 | 32,046 | +125.0% | $416K | $13.01 |
| Q3 2024 | 1 | 14,244 | — | $130K | $9.19 |